Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Real-World Effectiveness of Tafasitamab (Tafa) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the United States

Kimberly Saverno, Loretta Nastoupil, Bruce Feinberg, John Galvin, Prathamesh Pathak, Theresa Amoloja, Danielle Gentile, Parisa Asgarisabet, Narendranath Epperla

Blood (2024) 144 (Supplement 1): 2375.

https://doi.org/10.1182/blood-2024-193264

Published: 2024

Journal Articles

Real-World Use of Tafasitamab (tafa) for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Among Racial and Ethnic Minorities in the United States

Narendranath Epperla, Loretta J. Nastoupil, Kristin M. Zimmerman Savill, Bruce Feinberg, John Galvin, Prathamesh Pathak, Sarah Gordon, Theresa Amoloja, Mae Llorente, Kimberly Saverno

Blood (2023) 142 (Supplement 1): 2415.

https://doi.org/10.1182/blood-2023-173456

Published: 2023

Journal Articles

Tafasitamab for the Treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the US Real-World Setting

Kimberly Saverno, Kristin M. Zimmerman Savill, Bruce Feinberg, John Galvin, Prathamesh Pathak, Sarah Gordon, Theresa Amoloja, Mae Llorente, Narendranath Epperla, Loretta J. Nastoupil

Blood (2023) 142 (Supplement 1): 265.

https://doi.org/10.1182/blood-2023-173143

Published: 2023

Journal Articles

Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups

Elizabeth A. Brem, John M. Burke, Mirko Vukcevic, Pia Kloepfer, Kimberly Saverno, Haifaa Abdulhaq, Andrew M Evens, Pierluigi Porcu, Mazyar Shadman, Christopher R. Flowers

Blood (2023) 142 (Supplement 1): 6251.

https://doi.org/10.1182/blood-2023-188482

Published: 2023